Drug and Alcohol Rehab Clinic Offers Employee Assistance Program (EAP)
Drug and Alcohol Rehab Clinic offers Employee Assistance Program (EAP) — Walter, an Employee Assistance Program (EAP) Counselor in industry, refers patients to the drug and alcohol rehab clinic at Brighton Center for Recovery in M…
Alcoholism rehab leader forays… Continue reading
Tampa Drug Detox Introduces Updated Women's Program for Rehabilitation …
Tampa Drug Detox Introduces Updated Women's Program for Rehabilitation …
Tampa Drug Detox Introduces Updated Women's Program for Rehabilitation from Prescription Drugs. A Tampa drug detox center offers new female-only program to stop drug dependency. Call (855) 912-7867 for an… Continue reading
New Fully Customizable Treatments Available at Drug Rehab Center …
New Fully Customizable Treatments Available at Drug Rehab Center …
Drug Rehab Center Conshohocken now offers even more therapeutic options that can be used to create a personalized treatment program for each and every patient. The addiction and recovery specialists… Continue reading
Treatment for US Opioid Addicts Often Inadequate, Researchers Say
Treatment for US Opioid Addicts Often Inadequate, Researchers Say
He spoke to the PBS NewsHour recently about the current state of opioid addiction treatment, options for closing some of the existing gaps and how the Affordable Care Act might play… Continue reading
A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.
A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.
J Addict Med. 2013 Jul 26;
Wei X, Wang L, Wang X, Li J, Li H, Jia W
We analyzed a 6-year methadone maintenance treatment (MMT) retention rate in 8 MMT clinics in Xi’an and the factors that influenced the retention rate.We conducted a 6-year retrospective dynamic cohort study of 5849 eligible patients from 2006 to 2011. Participants were serially enrolled on the basis of opioid addiction, age, residence status, and civil capacity. Cumulative retention in treatment was calculated using survival analyses (life tables) on the basis of the number of days in MMT. We also used the Cox proportional hazard regression model to analyze the factors that may influence treatment retention.The MMT retention varied from a less than 1 month to a maximum of 71.2 months; the average dose was 48.76 ± 17.03 mg/d. The cumulative retention for 12, 24, 36, 48, 60, and 72 months after MMT initiation were 0.87, 0.76, 0.66, 0.57, 0.49, and 0.43, respectively. The MMT retention rate was significantly associated with factors that included the particular clinic for MMT, the year when the subject initiated MMT, average daily dose, hidden drug use, sex, age, length of drug abuse history, needle sharing, living arrangements, and employment status.The 6-year retention rates for MMT in the 8 clinics in Xi’an were higher than those reported in other studies of other clinics. High therapeutic doses (>60 mg/d) could reduce the risk of… Continue reading
Asean's 2015 Drug–Free Target 'Unrealistic'
Asean's 2015 Drug–Free Target 'Unrealistic'
Authorities then herd thousands of drug users into compulsory treatment centres, ignoring evidence-based approaches, and despite a joint UN statement in 2012 calling for the closure of such centers, which are deemed costly… Continue reading
Decreased Mitochondrial DNA Copy Number in the Hippocampus and Peripheral Blood During Opiate Addiction Is Mediated by Autophagy and Can Be Salvaged by Melatonin.
Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin.
Autophagy. 2013 Jun 20; 9(9):
Feng YM, Jia YF, Su LY, Wang D, Lv L,… Continue reading
Collaborative Stepped Care v. Care as Usual for Common Mental Disorders: 8-Month, Cluster Randomised Controlled Trial.
Collaborative stepped care v. care as usual for common mental disorders: 8-month, cluster randomised controlled trial.
Br J Psychiatry. 2013 Jun 20;
Oosterbaan DB, Verbraak MJ, Terluin B, Hoogendoorn AW, Peyrot WJ, Muntingh A, van Balkom AJ
Thus far… Continue reading